 "Zydus")
Ahmedabad-based drug maker Cadila Healthcare Ltd (Zydus Cadila) in Friday announced a consolidated net profit of Rs 303.6 crore for the quarter ended June 30, 2019 (Q1FY20). As against this, the company's Q1 consolidated net profit for the previous fiscal stood at Rs 460.5 crore.
The fall in net profit, among other factors, is likely to be on account of a rise in cost of materials which stood at Rs 723.5 crore in Q1FY20 as against Rs 632.9 crore in Q1FY19. Finance costs too, almost trebled for the company from Rs 35 crore in Q1FY19 to Rs 89.1 crore
The fall in net profit, among other factors, is likely to be on account of a rise in cost of materials which stood at Rs 723.5 crore in Q1FY20 as against Rs 632.9 crore in Q1FY19. Finance costs too, almost trebled for the company from Rs 35 crore in Q1FY19 to Rs 89.1 crore
